Evidence map›Paper›PMID 38874433›Full record

ArticleExperimental dermatology2024

miR-4521-A novel biomarker for human lentigos.

Hiroshi Maeno, Yoko Suzuki-Horiuchi, Ayaka Funakoshi, Onuma Chumsakul, Yasunari Sato, Tsuyoshi Ishii, John T Seykora

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Experimental dermatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hiroshi MaenoDepartment of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID https://orcid.org/0009-0007-6547-7183
Yoko Suzuki-HoriuchiDepartment of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID https://orcid.org/0000-0003-3800-6160
Ayaka FunakoshiDermatology Research Group, Basic Research Development Division, Rohto Pharmaceutical Co., Ltd, Osaka, Japan.ORCID https://orcid.org/0009-0009-4567-5865
Onuma ChumsakulDermatology Research Group, Basic Research Development Division, Rohto Pharmaceutical Co., Ltd, Osaka, Japan.ORCID https://orcid.org/0009-0007-1737-6046
Yasunari SatoDermatology Research Group, Basic Research Development Division, Rohto Pharmaceutical Co., Ltd, Osaka, Japan.ORCID https://orcid.org/0000-0003-2173-8488
Tsuyoshi IshiiDermatology Research Group, Basic Research Development Division, Rohto Pharmaceutical Co., Ltd, Osaka, Japan.ORCID https://orcid.org/0000-0001-9174-2744
John T SeykoraDepartment of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID https://orcid.org/0000-0003-0383-031X

Funding

Study Design and Data AnalysisP30AR069589 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI Elizabeth Anne Grice · 2016 to 2026
$8.6M
Mechanisms regulating the early stages of UV-induced skin cancerR01ES028114 · NIEHS · UNIVERSITY OF PENNSYLVANIA · PI SEYKORA, JOHN T. · 2018 to 2022
$1.8M
NIAMS NIH HHS P30 AR069589NIEHS NIH HHS R01 ES028114NIH HHSRohto Pharmaceutical Co., Ltd
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BiomarkersLentigoMicroRNAsFemaleHumansMaleMiddle AgedBiomarkersMicroRNAsautophagyin situ hybridizationlentigomiRNAqRT‐PCR

Identifiers

PMID38874433
PMCPMC11252838

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.